88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Announcement of Paper Publication: EditForce Demonstrates Efficacy of Treatment for Myotonic Dystrophy Type 1 Using PPR Platform Technology FUKUOKA, Japan , April 25, 2025 /PRNewswire/ -- EditForce, Inc. (Headquarters: Fukuoka, Japan ) is pleased to announce that a research paper on the results of a joint study with the research group ... 2025-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals Publishing/Information Service
Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Gastrointestinal Cancers CHENGDU, China , April 25, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") recently announced CM518D1, a CDH17-targeted antibody-drug ... 2025-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Akeso Announces FDA Approval for Penpulimab-kcqx in Two BLA Indications for Comprehensive Treatment of Advanced Nasopharyngeal Carcinoma HONG KONG , April 25, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its ... 2025-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Non-Infectious Anterior Uveitis VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the standard therapy, prednisolone acetate (PA) ... 2025-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Primo's Taoyuan Facility Achieves PIC/S GMP Certification, Paving the Way for Global Expansion in Nuclear Medicine. TAIPEI , April 24, 2025 /PRNewswire/ -- Primo Biotechnology Co., Ltd. ("Primo") proudly announces that its Taoyuan pharmaceutical facility has successfully passed inspection by Taiwan Food ... 2025-04-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Mabwell to Present Clinical Data of 9MW2821 Combined with Toripalimab in Patients with UC in an Oral Presentation at 2025 ASCO SHANGHAI , April 24, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase Ib/II clinical study results ... 2025-04-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Dizal to Showcase Data in Hematologic Malignancies and Lung Cancer at ASCO 2025 DZD8586 study results in B-cell non-Hodgkin lymphomas (B-NHLs) were selected for oral and poster presentations. The analysis in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after ... 2025-04-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SWS Medical and Hemotek - Partners in Innovations at the 45th Philippine Society of Nephrology Annual Convention MANILA, Philippines , April 24, 2025 /PRNewswire/ -- SWS Medical, a leading Chinese blood purification provider, is excited to participate in the 45th Philippine Society of Nephrology Annual Convention ... 2025-04-24T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Kelun-Biotech to Present Results of Six Clinical Studies at 2025 ASCO Annual Meeting CHENGDU, China , April 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) announced that it will present results from six Kelun-led clinical studies at the 2025 ... 2025-04-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene to Present Latest Results From Two Clinical Studies at ASCO 2025 SHANGHAI and HONG KONG , April 24, 2025 /PRNewswire/ -- Antengene Corporation Limited (" Antengene ", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company ... 2025-04-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2025

Suntek Computer Systems Limited.

All rights reserved